Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 8

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 7,001–8,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
7001Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T146ECGU0001460.18
7002CDC37/SNX9 ratioGCST903139360.18
7003Phospholipids to Total Lipids in Medium HDL percentageGCST904986510.18
7004Monounsaturated fatty acids levels (UKB data field 23447)GCST902695440.18
7005Free cholesterol levels in very large HDLGCST900930080.18
7006C9 Carnitine levels in chronic kidney diseaseGCST902576820.18
7007HMOX1 levelsGCST904694650.18
7008RNASE1 levelsGCST904704760.18
7009PVR levelsGCST904703940.18
7010Benign neoplasm of eye (PheCode 224)GCST904756260.18
7011UrolithiasisGCST900187150.18
7012Omega-6 fatty acids to total fatty acids percentage (UKB data field 23452)GCST902695490.18
7013Left ventricular ejection fractionGCST902681250.18
7014XIAP levelsGCST904710830.18
7015Monounsaturated fatty acid levelsGCST905020360.18
7016Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)FING000007660.18
7017Eye problems/disorders - Cataract | EyesightUKBB000002300.18
7018Number of correct matches in round | Pairs matchingUKBB000005320.18
7019Triglycerides in small HDL (UKB data field 23578)GCST902696750.18
7020NELL1 levelsGCST904700260.17
7021Saturated fatty acids levelsGCST905021860.17
7022ROR1/THBD ratioGCST903157860.17
7023Colorectal cancer (PheCode 153)GCST0083720.17
7024GRP levelsGCST904694060.17
7025IDP dMRI ProbtrackX ICVF cgc rGCST900043800.17
7026Behenoyl dihydrosphingomyelin (d18:0/22:0) levelsGCST902000590.17
7027CD84/GP6 ratioGCST903139140.17
7028EFCAB14 levelsGCST904690760.17
7029Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285ECGA0002850.17
7030Takes medication for prostate cancer?GCST904751870.17
7031Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivityGCST903027100.17
7032N-acetylcarnosine levelsGCST901999260.17
7033Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161ECGU0001610.17
7034TYRO3 levelsGCST904709970.17
7035Erectile dysfunctionGCST0069560.17
7036Total esterified cholesterol levelsGCST905000340.17
7037wg rh intensity-contrast lateralorbitofrontalGCST900038380.17
7038LY6G6C levelsGCST902418300.17
7039GP2 levelsGCST904693820.17
7040HippSubfield rh volume presubiculum-bodyGCST900026970.17
7041IDP dMRI TBSS ICVF Anterior corona radiata RGCST900043490.17
7042Other chronic obstructive pulmonary disease | Chronic lower respiratory diseasesUKBB000006040.17
7043Osteoporosis (PheCode 743.1)GCST904763840.17
7044SMPD3 levelsGCST904706850.17
7045OMD/SPP1 ratioGCST903155860.17
7046COL1A1/SOST ratioGCST903141720.17
7047Cystatin C productionGCST902679860.17
7048CD99/CD99L2 ratioGCST903139230.17
7049CR1 levelsGCST904688510.17
7050Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163ECGU0001630.17
7051Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418ECGU0004180.17
7052SH3GLB2 levelsGCST904706210.17
7053DTI autoptx MD slf l tractGCST903852410.17
7054Milk type: Skimmed, semi-skimmed or full cream (UKB data field 1418)GCST901330050.17
7055Concentration of medium VLDL particles (UKB data field 23502)GCST902695990.17
7056WFIKKN2 levelsGCST904221270.17
7057Systolic blood pressure, manual reading | Blood pressureUKBB000008100.17
7058PM: initial answer - Orange circle| Prospective memoryUKBB000006520.17
7059Cholesterol to Total Lipids in Medium HDL percentageGCST904985190.17
7060CCL28 levelsGCST904685800.17
7061Phospholipid levels in very small VLDLGCST900930360.17
7062Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906685050.17
7063Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70ECGA0000700.17
7064T1 CAT volume L CingulateGyrusanteriordivisionGCST903840560.17
7065Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T137ECGU0001370.17
7066Right-hemisphere control network to hippocampus white-matter structural connectivityGCST903028400.17
7067Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143ECGA0001430.17
7068Leisure/social activities - Sports club or gym | Social supportUKBB000004020.17
7069GALNT2 levelsGCST904692960.17
7070C4 levelsGCST902810420.17
7071Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134ECGU0001340.17
7072Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T245ECGA0002450.17
7073Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159ECGU0001590.17
7074WFDC12 levelsGCST904710730.17
7075Prescriptions - antispasmodicUKBB000006660.17
7076IDP dMRI TBSS ISOVF Anterior corona radiata LGCST900045000.17
7077TNFSF12/TNFSF13 ratioGCST903159410.17
7078MITD1/RHOC ratioGCST903154530.17
7079T1 FreeSurfer DK lh MeanThickness thicknessGCST903856560.17
7080SSC-A on plasmacytoid Dendritic CellGCST900020720.17
7081Free Cholesterol to Total Lipids in Large LDL percentageGCST904980070.17
7082Spleen iron concentrationGCST901018310.17
7083ITGB5/VSIR ratioGCST903152350.17
7084THBD levelsGCST904708530.17
7085DTI TBSS FA External capsule RGCST903844120.17
7086Free cholesterol in very large HDLGCST905003830.17
7087Pork consumptionGCST901329990.17
7088Diacylglycerol_34:1_[M+H-H2O]1+ levelsGCST900601790.17
7089CRNN levelsGCST904688690.17
7090Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268ECGU0002680.17
7091Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82ECGU0000820.17
7092Duration screen displayed | Prospective memoryUKBB000002010.17
7093Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T89ECGA0000890.17
7094Phenylalanine levelsGCST900929360.17
7095Obstructive chronic bronchitis | respiratoryUKBB000005460.17
7096IDO1 levelsGCST902414900.17
7097BCAM/CLEC14A ratioGCST903134700.17
7098PSRC1/SMAD1 ratioGCST903157410.17
7099IL6R levelsGCST904696020.17
7100Osteoarthritis (self-reported)GCST0058110.17
7101MDGA1 levelsGCST904698750.17
7102Lymphocyte countGCST900023170.17
7103Cholesterol to total lipids in large LDL percentage (UKB data field 23615)GCST902697120.17
7104GFER/VASH1 ratioGCST903149220.17
7105Monocyte count | Blood countUKBB000004790.17
7106Brugada syndromeGCST900861580.17
7107FETUB levelsGCST904692150.17
7108Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153ECGU0001530.17
7109Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T272ECGA0002720.17
7110PM: initial answer - Blue square | Prospective memoryUKBB000006510.17
7111CRHBP/TREM2 ratioGCST903142600.17
71125alpha-androstan-3beta,17beta-diol monosulfate (2) levelsGCST901998550.17
7113APOB/APOA1 ratioGCST900928100.17
7114rfMRI connectivity (ICA100 edge 951)GCST900058040.17
7115Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991990.17
7116Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T287ECGA0002870.17
7117Triglycerides to total lipids ratio in large LDLGCST900928670.17
7118IDP dMRI TBSS L2 Superior cerebellar peduncle RGCST900041350.17
7119F11R/TMSB10 ratioGCST903147290.17
7120Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989440.17
7121SDHB levelsGCST904705610.17
7122MSTN/RGMA ratioGCST903155040.17
7123DTI autoptx L3 fmi tractGCST903852040.17
7124Chronic venous insufficiency [CVI] (PheCode 456)GCST904760160.16
7125FLT3 levelsGCST904692510.16
7126Cholesteryl esters to total lipids ratio in medium HDLGCST900928950.16
7127FGFR2/TGFBR2 ratioGCST903148130.16
7128UFC1 levelsGCST902432450.16
7129Ulcerative colitisGCST900187130.16
7130SPINK5/SPINT1 ratioGCST903158770.16
7131aparc-a2009s lh area G-parietal-supGCST900033230.16
7132Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482ECGA0004820.16
7133CLIP2/DNAJA2 ratioGCST903141270.16
7134DRG2/SEMA4D ratioGCST903145540.16
7135aparc-Desikan rh area isthmuscingulateGCST900031160.16
7136PTPN6/YES1 ratioGCST903157500.16
7137Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST902001030.16
7138Left-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903027500.16
7139Principal component-derived dietary pattern 2GCST901330070.16
7140Facial wrinkles (under eye)GCST900949030.16
7141Total triglycerides levelsGCST900929920.16
7142FKBP5/TBCC ratioGCST903148490.16
7143IFNG levelsGCST904695150.16
7144Neutrophil countGCST0046290.16
7145CREG1 levelsGCST904688570.16
7146Neutrophil countGCST900023510.16
7147Average diameter for LDL particlesGCST904984580.16
7148IDP dMRI ProbtrackX L3 str rGCST900043240.16
7149T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855340.16
7150FUT8/TNFSF12 ratioGCST903148940.16
7151Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028340.16
7152Cholesteryl ester_14:0_[M+NH4]1+ levelsGCST900601970.16
7153Retrobulbar neuritis in diseases classified elsewhereFING000012650.16
7154aparc-pial lh area lateralorbitofrontalGCST900031520.16
7155Mean corpuscular hemoglobin varianceGCST905656930.16
7156CXCL5 levelsGCST904689320.16
7157Triglyceride levels in chylomicrons and extremely large VLDLGCST905010680.16
7158IL1R2/MEGF9 ratioGCST903151590.16
7159FAM174A levelsGCST902419140.16
7160Total lipid levels in medium HDLGCST900928980.16
7161Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660160.16
7162Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T182ECGA0001820.16
7163Cholesteryl esters in small HDL (UKB data field 23576)GCST902696730.16
7164Comparative body size at age 10 | Early life factorsUKBB000001420.16
7165GCG levelsGCST904693160.16
7166Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905021470.16
7167AsthmaGCST0068620.16
7168DTI autoptx L3 ifo l tractGCST903852050.16
71691-(1-enyl-palmitoyl)-GPC (p-16:0) levelsGCST901998990.16
7170CLEC1B/SNAP29 ratioGCST903141030.16
7171DAG1/GP6 ratioGCST903143750.16
7172SERPINE1/SPARC ratioGCST903158340.16
7173ACTA2 levelsGCST904682080.16
7174LGALS8 levelsGCST904697640.16
7175CD84/DAG1 ratioGCST903139100.16
7176IDP T1 FAST ROIs V cerebellum crus IIGCST900025730.16
7177Sum neutrophil eosinophil countsGCST0046130.16
7178rfMRI amplitudes (ICA100 node 28)GCST900046160.16
7179Phenylacetate levelsGCST901996300.16
7180Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211)GCST900435520.16
7181PTPN1 levelsGCST904703760.16
7182Seborrhoeic keratosisFING000012830.16
7183EREG levelsGCST904691450.16
7184GOT1 levelsGCST904693790.16
7185CEACAM19 levelsGCST904686910.16
7186TDRKH/TST ratioGCST903159130.16
7187BCAN/CD200 ratioGCST903134770.16
7188CCL5/CXCL3 ratioGCST903137000.16
7189IL18RAP levelsGCST904695660.16
7190Myocardial fractal dimension (slice 5)GCST900002910.16
7191CD83/LAMP3 ratioGCST903139060.16
7192aparc-a2009s lh area G-precentralGCST900033250.16
7193aparc-DKTatlas rh volume pericalcarineGCST900029120.16
7194Bell pepper likingGCST900947030.16
7195RETN levelsGCST904704570.16
7196PAFAH1B3 levelsGCST904701450.16
7197Left ventricular end diastolic volume (indexed to body surface area)GCST904352580.16
7198Chronic airway obstruction | respiratoryUKBB000001350.16
7199DKK1/PPCDC ratioGCST903144770.16
7200CD200/CNTNAP2 ratioGCST903137470.16
7201Anti-human herpes virus 6 IE1A IgG seropositivityGCST900069030.16
7202Phosphatidylcholine (14:0_22:6) levelsGCST900242340.16
7203HEXIM1/NUB1 ratioGCST903150490.16
7204MMP7 levelsGCST904699210.16
7205Concentration of HDL particlesGCST900928260.16
7206PCDH12 levelsGCST904701680.16
7207CTSE levelsGCST904689110.16
7208SERPINA5 levelsGCST904705850.16
7209Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86ECGU0000860.16
7210DTI autoptx L3 ilf r tractGCST903852080.16
7211HBEGF/YES1 ratioGCST903150390.16
7212MTSS2 levelsGCST904699610.16
7213ADIPOQ levelsGCST902930860.16
7214PSTPIP2 levelsGCST904703660.16
7215Triglycerides to Total Lipids in IDL percentageGCST904976820.16
7216Triglycerides in large LDLGCST904980830.16
7217T1 FreeSurfer aseg Right-PallidumGCST903841640.16
7218Saturated fatty acids levelsGCST904999530.16
7219Cerebrospinal fluid sulfate* levelsGCST903180560.16
7220Free Cholesterol to Total Lipids in Small LDL percentageGCST904996370.16
7221IDP T1 FAST ROIs L cerebellum crus IGCST900025690.16
7222Hip circumference (UKB data field 49)GCST904681700.16
7223TIMP4 levelsGCST904708720.16
7224Plasma lysine levels in chronic kidney diseaseGCST902654590.16
7225Hearing difficulty with background noiseGCST902457750.16
7226Honey likingGCST900947820.16
7227TEK levelsGCST900120130.16
7228Free cholesterol levels in VLDLGCST900929980.16
7229DKK1/VASH1 ratioGCST903144820.16
7230DDC levelsGCST904689670.16
7231CASP3/PDGFA ratioGCST903136370.16
7232T1 FreeSurfer a2009s rh G cuneus volumeGCST903850480.16
7233Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182160.16
7234CPB1 levelsGCST902405970.16
7235TRAF3 levelsGCST904709570.16
7236Lymphangioleiomyomatosis (sporadic)GCST0083110.16
7237Total lipids in medium VLDLGCST904990040.15
7238Atrial fibrillation and flutter | Other forms of heart diseaseUKBB000000560.15
7239RGMA levelsGCST904704630.15
7240Concentration of medium VLDL particlesGCST904990160.15
7241Sphingomyelins levelsGCST904999720.15
7242Volume of right central nucleusGCST904750270.15
7243Regional enteritis (PheCode 555.1)GCST904760660.15
7244Cholesteryl Esters to Total Lipids in IDL percentageGCST904975390.15
7245Malignant neoplasm of female breast (PheCode 174.11)GCST900418330.15
7246Severe hearing loss or partial deafness in one or both earsGCST904753850.15
7247Duration of vigorous activity | Physical activityUKBB000001990.15
7248MERTK levelsGCST904698900.15
7249Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452ECGU0004520.15
7250CD302/CD99 ratioGCST903138050.15
7251PAG1 levelsGCST904701470.15
7252IDP dMRI TBSS FA Sagittal stratum RGCST900039070.15
7253Sum basophil neutrophil countsGCST0046200.15
7254Cholesterol in IDLGCST904975010.15
7255Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58ECGA0000580.15
7256HMBS/PKLR ratioGCST903150630.15
7257aparc-a2009s lh volume G-pariet-inf-SupramarGCST900029500.15
7258ENO2/MANF ratioGCST903146620.15
7259Number of attempts | Prospective memoryUKBB000005310.15
7260RAB11FIP3 levelsGCST904704040.15
7261Sjögren's syndromeGCST900187000.15
7262DKK1/SERPINE1 ratioGCST903144800.15
7263Colorectal cancer (PheCode 153)GCST904755660.15
7264Free Cholesterol in HDLGCST904973790.15
7265IDP dMRI TBSS L3 Inferior cerebellar peduncle LGCST900041820.15
7266IDP dMRI TBSS ICVF Posterior corona radiata LGCST900043540.15
7267Alpha-hydroxyisovalerate levelsGCST901997360.15
7268LAT/SERPINE1 ratioGCST903152870.15
7269Cholesterol to Total Lipids in IDL percentageGCST904975110.15
7270T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 20)GCST903208390.15
7271MPIG6B/SUSD1 ratioGCST903154870.15
7272Nonspecific chest pain (PheCode 418)GCST904759470.15
7273Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408ECGU0004080.15
7274Height decline (log-difference score)GCST905658530.15
7275VLDL cholesterol levels (UKB data field 23403)GCST902695000.15
7276ANGPT1/SERPINE1 ratioGCST903132690.15
7277Fracture of upper limb (PheCode 803)GCST904762790.15
7278CD22/FCRL1 ratioGCST903137570.15
72792s,3R-dihydroxybutyrate levelsGCST901998820.15
7280Free cholesterol to total lipids ratio in medium LDLGCST900929090.15
7281Triglycerides to Total Lipids in Very Large HDL percentageGCST905005060.15
7282PRCP/SELE ratioGCST903157260.15
7283Total free cholesterol levelsGCST905000720.15
7284INSL5 levelsGCST904696220.15
7285INSL4 levelsGCST904696210.15
7286Granulocyte countGCST0046140.15
7287PPP1R2/TBL1X ratioGCST903157200.15
7288CALB2 levelsGCST904685270.15
7289Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T142ECGA0001420.15
7290Omega-3 fatty acid levelsGCST905024240.15
7291Platelet countGCST902786400.15
7292Free cholesterol to total lipids ratio in IDLGCST900928360.15
7293Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147ECGU0001470.15
7294High light scatter reticulocyte countGCST0046110.15
7295Cholesterol levels in chylomicrons and extremely large VLDLGCST905009180.15
7296Cholesterol to Total Lipids in Large LDL percentageGCST904979290.15
7297HGF/PLAUR ratioGCST903150590.15
7298Pregnancy with abortive outcomeFING000012050.15
7299ACAA1 levelsGCST904681930.15
7300CCN2/VEGFC ratioGCST903137190.15
7301Monounsaturated fatty acids to total fatty acids percentageGCST905023730.15
7302T1 CAT volume R RightPutamenGCST903841010.15
7303B4GALT1/IFNGR1 ratioGCST903134300.15
7304CEBPB/PXN ratioGCST903140080.15
7305RNF43 levelsGCST904224820.15
7306DTI TBSS MD Splenium of corpus callosumGCST903845760.15
7307IQGAP2/STX4 ratioGCST903151900.15
7308Prostate cancerGCST902747160.15
7309Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998310.15
7310IL27 levelsGCST900120170.15
7311UPB1 levelsGCST904710130.15
7312Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171ECGU0001710.15
7313Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T267ECGA0002670.15
7314aparc-a2009s rh volume S-oc-temp-med+LingualGCST900030590.15
7315Phospholipids to Total Lipids in Medium HDL percentageGCST904986530.15
7316Cerebral amyloid angiopathyFING000002620.15
7317F11R/SORT1 ratioGCST903147260.15
7318DTI TBSS MD Posterior thalamic radiation LGCST903846010.15
7319IDP dMRI TBSS ICVF Anterior limb of internal capsule RGCST900043430.15
7320LGALS9 levelsGCST904697650.15
7321NUDT5/RWDD1 ratioGCST903155800.15
7322SFTPA2/SFTPD ratioGCST903158390.15
7323CDSN/KLK8 ratioGCST903139960.15
7324Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T53ECGU0000530.15
7325AFM levelsGCST904682490.15
7326Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005130.15
7327Free Cholesterol to Total Lipids in IDL percentageGCST904975760.15
7328TNFRSF13B/TNFRSF9 ratioGCST903159320.15
7329RNF146 levelsGCST904214790.15
7330Free cholesterol in medium VLDL (UKB data field 23507)GCST902696040.15
7331PAPPA levelsGCST904701570.15
7332THOP1 levelsGCST904708560.15
7333CAG-273 sp003507395 abundance in stoolGCST900322690.15
7334Triglycerides in small LDLGCST904997120.15
7335PLXNB3 levelsGCST904702670.15
7336Thyroiditis, unspecifiedFING000013590.15
7337ENO2/RWDD1 ratioGCST903146670.15
7338Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162ECGU0001620.15
7339Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivityGCST903027350.15
7340VEGFD levelsGCST900120690.14
7341Phospholipids to Total Lipids in Small VLDL percentageGCST904999020.14
7342Irregular menstrual cycle/bleeding | genitourinaryUKBB000003790.14
7343IDP T1 FAST ROIs R cerebellum VIGCST900025680.14
7344ITIH3/VCAM1 ratioGCST903152360.14
7345Cholesterol to total lipids in very small VLDL percentage (UKB data field 23605)GCST902697020.14
7346Total lipids in small LDLGCST904996560.14
7347Total cholesterol levelsGCST905000220.14
7348PDGFB/PRKAR1A ratioGCST903156240.14
7349Beef consumption (UKB data field 1369)GCST901329970.14
7350Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141ECGA0001410.14
7351CLIP2/LAT2 ratioGCST903141280.14
7352PSRC1 levelsGCST904703650.14
7353Phospholipids in medium HDLGCST904986410.14
7354Total lipids in medium HDLGCST904985970.14
7355S100A4/SNAP29 ratioGCST903158010.14
7356Chronic bronchitisGCST900186040.14
7357Venous thromboembolismFING000014270.14
7358LDL cholesterol levelsGCST904983530.14
7359Ceramide_40:1_[M-H]1- levelsGCST900601980.14
7360PTPRF levelsGCST904703810.14
7361RadiculopathyFING000012380.14
7362Infections of the skin and subcutaneous tissueFING000006700.14
7363Triglycerides to total lipids in medium LDL percentage (UKB data field 23623)GCST902697200.14
7364Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371ECGA0003710.14
7365Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levelsGCST902001180.14
7366ADH4/KYNU ratioGCST903131930.14
7367CKAP4/PGF ratioGCST903140750.14
7368SPINK4 levelsGCST904707230.14
7369ITGB1/MCAM ratioGCST903152260.14
7370GM3 ganglioside (d18:1/24:0) levelsGCST900253400.14
7371Phospholipids in very small VLDL (UKB data field 23518)GCST902696150.14
7372Concentration of large LDL particlesGCST904980290.14
7373Takes medication for Diabetes/sugar?GCST904752680.14
7374ARSA/CD164 ratioGCST903133510.14
7375Lysophosphatidylcholine (24:0) [sn1] levelsGCST900254250.14
7376Spondylosis and allied disorders (PheCode 721)GCST904762350.14
7377PDLIM7 levelsGCST904701980.14
7378Worrier / anxious feelings | Mental healthUKBB000009210.14
7379VLDL cholesterol levelsGCST905001960.14
7380BCAN levelsGCST904684260.14
7381Phospholipid levels in VLDLGCST900930010.14
7382APOA1 levelsGCST904971190.14
7383ADA levelsGCST904682310.14
7384Triglycerides in very small VLDL (UKB data field 23522)GCST902696190.14
7385IDP dMRI TBSS ICVF Superior corona radiata LGCST900043520.14
7386LZTFL1 levelsGCST904698340.14
7387Triglycerides to total lipids in small LDL percentage (UKB data field 23628)GCST902697250.14
7388Triglycerides in IDLGCST904976610.14
7389Docosahexaenoic acid to total fatty acids percentageGCST905022680.14
7390LYVE1 levelsGCST904698320.14
7391Concentration of small LDL particlesGCST904996600.14
7392Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST902697060.14
7393FLT1/TGFB1 ratioGCST903148570.14
73945alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST901998540.14
7395Saturated fatty acids levelsGCST905026700.14
7396Cholesterol to total lipids in medium LDL percentage (UKB data field 23620)GCST902697170.14
7397Cereal type - Muesli | DietUKBB000001230.14
7398Vanillactate levelsGCST901999780.14
7399PLIN3/TYMP ratioGCST903156780.14
7400LDL (weighted GWA)GCST902672730.14
7401Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T197ECGU0001970.14
7402AMOT levelsGCST904682950.14
7403Eosinophil count varianceGCST905656890.14
7404CD244/CD84 ratioGCST903137620.14
7405Total lipids in large LDLGCST904980210.14
7406Childhood body mass indexGCST900024090.14
7407Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T66ECGA0000660.14
7408Alcohol usually taken with meals | AlcoholUKBB000000250.14
7409CBLIF levelsGCST904685520.14
7410BSG/CKAP4 ratioGCST903135310.14
7411RHOC levelsGCST904704670.14
7412Phospholipid levels in small HDLGCST900929520.14
7413Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026580.14
7414severe traumatic brain injury, does not include concussionFING000013000.14
7415Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST900931130.14
7416MESD/WWP2 ratioGCST903154260.14
7417wg rh intensity-contrast postcentralGCST900038480.14
7418COMT levelsGCST904688280.14
7419DTI autoptx FA slf r tractGCST903851340.14
7420Omega-3 fatty acids to total fatty acids percentageGCST904991550.14
7421NECTIN2 levelsGCST904700200.14
7422Right-hemisphere default mode network to thalamus white-matter structural connectivityGCST903028440.14
7423Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T92ECGU0000920.14
7424NBL1/TGFBR2 ratioGCST903155150.14
7425F-carbohydrate liking (derived food-liking factor)GCST900947250.14
7426Spread type: Butter vs never use spread (UKB data field 1428)GCST901329520.14
7427S100A11 levelsGCST904705120.14
7428ENPP5 levelsGCST904691160.14
7429Concentration of small HDL particles (UKB data field 23572)GCST902696690.14
7430Cholesterol in Large LDLGCST904979230.14
7431HLA-DQA2 levelsGCST904270490.14
7432ANG levelsGCST904683070.14
7433HBEGF levelsGCST902413920.14
7434Pulmonary heart disease (PheCode 415)GCST904759420.14
7435Volume of right medial nucleusGCST904750450.14
7436CCL8 levelsGCST904685860.14
7437Triglyceride levels in medium VLDLGCST900929260.14
7438Cerebral aneurysmGCST900185950.14
7439Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91ECGU0000910.14
7440Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivityGCST903028350.14
7441Ratio of monounsaturated fatty acids to total fatty acidsGCST900929290.14
7442monocyte (absolute count, mean, inv-norm transformed)GCST904755020.14
7443Illnesses of father - High blood pressure | Family historyUKBB000003430.14
7444NECTIN2/TNFRSF14 ratioGCST903155310.14
7445CD27/CD79B ratioGCST903137700.14
74465-hydroxyindole sulfate levelsGCST902000500.14
7447Triacylglycerol_52:6_[M+NH4]1+ levelsGCST900605040.14
7448aseg rh volume Cerebellum-CortexGCST900026360.14
7449KLK6 levelsGCST900120080.14
7450Peripheral vascular diseaseGCST904752190.14
7451Volume of left central nucleusGCST904748830.14
7452Triglycerides to total lipids in large VLDL percentage (UKB data field 23593)GCST902696900.14
7453FCGR2A/FCGR2B ratioGCST903147930.14
7454Omega-3 fatty acids to total fatty acids percentageGCST905024630.14
7455Plasma iron levelsGCST901005460.14
7456CLEC1A/CLEC7A ratioGCST903140830.14
7457IDP dMRI TBSS L1 Anterior corona radiata RGCST900040970.14
7458SPARC/TJAP1 ratioGCST903158730.14
7459Cholesteryl esters to total lipids ratio in very large VLDLGCST900930190.14
7460aparc-a2009s rh volume S-intrapariet+P-transGCST900030540.14
7461Atrial fibrillation and flutter | circulatory systemUKBB000000550.13
7462T1 FreeSurfer DKT lh lateraloccipital areaGCST903842020.13
7463RARRES2 levelsGCST904704280.13
7464ITGA5/SELE ratioGCST903152050.13
7465IDP dMRI TBSS ICVF Superior cerebellar peduncle RGCST900043390.13
7466Triglyceride levels in small VLDLGCST901326670.13
7467DOK2/FADD ratioGCST903145300.13
7468Docosahexaenoic acid levelsGCST905019860.13
7469PLA2G4A/SDC4 ratioGCST903156680.13
7470DTI TBSS FA Uncinate fasciculus LGCST903844250.13
7471Lateral epicondylitisFING000007150.13
7472LAT2/MANF ratioGCST903152770.13
7473MAVS/RNF41 ratioGCST903153950.13
7474PDGFB/UXS1 ratioGCST903156340.13
7475EIF4G1/FOXO1 ratioGCST903146340.13
7476Omega-3 fatty acids to total fatty acids percentageGCST905024660.13
7477ADH4/SCLY ratioGCST903131950.13
7478Thyroxine levelsGCST902002930.13
7479Free cholesterol levels in medium VLDLGCST900929200.13
7480COL2A1 levelsGCST904688160.13
7481monocyte (absolute count, maximum, inv-norm transformed)GCST904754990.13
7482LSP1 levelsGCST904698110.13
7483CCN2/ENO2 ratioGCST903137120.13
7484PDP1 levelsGCST904242960.13
7485Total fatty acid levelsGCST905000610.13
7486Hearing difficulty and hearing difficulty with background noiseGCST902457760.13
7487Average diameter for LDL particles (UKB data field 23432)GCST902695290.13
7488LDLR/PCSK9 ratioGCST903153110.13
7489ANGPT1/DKK1 ratioGCST903132630.13
7490EpiscleritisFING000005130.13
7491Operative procedures - Direct current cardioversion | Summary OperationsUKBB000005760.13
7492Other and unspecified iron deficiencyFING000009400.13
7493Androsterone sulfate levelsGCST902006740.13
7494CLEC14A/PTPRS ratioGCST903140810.13
7495CCN2 levelsGCST904685880.13
7496GATD3 levelsGCST904693090.13
7497DKK1/LGALS8 ratioGCST903144720.13
7498CSNK2A1 or CSNK2B levelsGCST900889630.13
7499Recent worrying too much about different things | AnxietyUKBB000007460.13
7500CLC/RNASE3 ratioGCST903140770.13
7501aparc-Desikan lh area precuneusGCST900030970.13
7502Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904996020.13
7503Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivityGCST903027590.13
7504Volume of right medial nucleusGCST904750420.13
7505Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)GCST902697080.13
7506Abnormal findings examination of lungs (PheCode 514)GCST904760430.13
7507Epiandrosterone sulfate levelsGCST901997520.13
7508CCN2/SERPINB1 ratioGCST903137150.13
7509WorryGCST0064780.13
7510CRKL/MGLL ratioGCST903142700.13
7511Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437ECGU0004370.13
7512XCL1 levelsGCST904710810.13
7513Concentration of IDL particlesGCST904976140.13
7514A4GALT levelsGCST904274570.13
7515aparc-Desikan rh area fusiformGCST900031130.13
7516PBXIP1 levelsGCST904701640.13
7517FABP1 levelsGCST904691730.13
7518DTI autoptx MD cgc r tractGCST903852250.13
7519AHSP/CA2 ratioGCST903132150.13
7520aparc-Desikan rh volume lingualGCST900028130.13
7521Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138ECGA0001380.13
7522Alcohol drinker status - Current | AlcoholUKBB000000210.13
7523Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T244ECGA0002440.13
7524METAP1D/VASH1 ratioGCST903154290.13
7525SCPEP1 levelsGCST904705530.13
7526Cholesterol levels in small VLDLGCST900929680.13
7527MARCO/SIGLEC1 ratioGCST903153870.13
7528Docosahexaenoic acid to total fatty acids percentageGCST905019990.13
75293-hydroxydecanoate metabolite levelGCST906154720.13
7530Prescriptions - ACE inhibitor|anti-hypertensiveUKBB000006570.13
7531SCRN1 levelsGCST904705560.13
7532GP6/SELP ratioGCST903149700.13
7533DKK1/PTPN6 ratioGCST903144780.13
7534COLEC12/NBL1 ratioGCST903141830.13
7535aparc-DKTatlas rh volume lingualGCST900029040.13
7536HDL cholesterol levelsGCST904973400.13
7537HDAC8 levelsGCST904694380.13
7538Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584)GCST902696810.13
7539Left-hemisphere default mode network to amygdala white-matter structural connectivityGCST903027720.13
7540BTC levelsGCST904684760.13
7541Right-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903028480.13
7542High cholesterolGCST904752030.13
7543DTI TBSS L3 Posterior thalamic radiation LGCST903845530.13
7544Omega-3 fatty acid levelsGCST905024250.13
7545PBLD levelsGCST904701630.13
7546MPO levelsGCST900120310.13
7547Cholesteryl ester levels in VLDLGCST900929970.13
7548Congenital malformations of genital organsFING000003330.13
7549Total cholines levelsGCST904971850.13
7550Left ventricular outflow tract obstruction (LVOTO), broad definitionFING000007170.13
7551VLDL cholesterol levelsGCST900929960.13
7552Citrate levelsGCST904972000.13
7553CALCOCO1/TBC1D5 ratioGCST903136100.13
7554Brainstem global volume Whole-brainstemGCST900027680.13
7555Concentration of small LDL particlesGCST904996690.13
7556rfMRI connectivity (ICA100 edge 912)GCST900057650.13
7557SERPINH1 levelsGCST904706010.13
7558Cholesteryl esters to total lipids in small HDL percentage (UKB data field 23646)GCST902697430.13
7559Cholesteryl Esters in IDLGCST904975250.13
7560X-13671 levelsGCST902438290.13
7561Cervicalgia (PheCode 761)GCST904762670.13
7562Concentration of LDL particlesGCST904984180.13
7563CD2AP levelsGCST904686170.13
7564MUC2 levelsGCST904699650.13
7565White blood cell countGCST902786470.13
7566Serum urea levelsGCST900259910.13
7567Collagenous colitisGCST902041450.13
7568X-21353 metabolite levelGCST906167080.13
7569Left-hemisphere visual network to pallidum white-matter structural connectivityGCST903026650.13
7570Coffee type - Instant coffee | DietUKBB000001410.13
7571LAYN levelsGCST904697420.13
7572Uterine fibroidsGCST900187140.13
7573IDP T1 FAST ROIs R mid front gyrusGCST900024580.13
7574DTI TBSS MD Superior corona radiata LGCST903845970.13
7575Otitis media and Eustachian tube disorders (PheCode 381)GCST904759020.13
7576CTSF levelsGCST904689120.13
7577Other ulcerative colitisFING000011170.13
7578DNAJC21 levelsGCST904690160.13
7579CKMB levelsGCST904752210.13
7580Concentration of very small VLDL particlesGCST900930350.13
7581CASP10/ING1 ratioGCST903136250.13
7582Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993350.13
7583Total lipid levels in small HDLGCST900929500.13
7584Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394ECGU0003940.13
7585Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002660.13
7586F-salty food liking (derived food-liking factor)GCST900948270.13
7587Free cholesterol in small VLDLGCST904998080.13
7588EFNA4/TNFRSF9 ratioGCST903146060.13
7589Linoleic acid to total fatty acids percentageGCST905023200.13
7590BCAN/KLK6 ratioGCST903134790.13
7591Cholesterol to total lipids ratio in very small VLDLGCST900930290.13
7592ACVRL1 levelsGCST904682110.13
7593CASP3/SERPINE1 ratioGCST903136430.13
7594Ptosis of eyelidFING000012270.13
7595Disorders of lipoprotein metabolism and other lipidaemiasFING000004420.13
7596Docosahexaenoic acid levelsGCST905022590.13
7597Omega-3 fatty acids to total fatty acids percentageGCST905024500.13
7598Other reaction to severe stress, and adjustment disordersFING000010920.13
7599CXCL14 levelsGCST904689270.13
7600Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivityGCST903027200.12
7601FCN1 levelsGCST904692030.12
7602KLK11/KLK8 ratioGCST903152540.12
7603GPC5 levelsGCST904693870.12
7604Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T137ECGA0001370.12
7605Benign neoplasm of colon (PheCode 208)GCST904756170.12
7606FADD/NCK2 ratioGCST903147700.12
7607Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA0001700.12
7608ANGPTL3 levelsGCST904683040.12
7609IDP dMRI TBSS OD Anterior limb of internal capsule LGCST900044190.12
7610Diacylglycerol_36:1_[M+H-H2O]1+ levelsGCST900601930.12
7611Brugada syndromeGCST902959160.12
7612Extrapyramidal and movement disordersFING000005270.12
7613MANF/SDC4 ratioGCST903153670.12
7614DLL1/NECTIN4 ratioGCST903144970.12
7615Physical activity (Total log acceleration 2am-4am)GCST900614100.12
7616Phospholipids in small VLDLGCST904998810.12
7617Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269ECGU0002690.12
7618LECT2 levelsGCST904697510.12
7619Ingrowing nail (PheCode 703.1)GCST904762080.12
7620LCAT levelsGCST904697450.12
7621CXCL11/CXCL13 ratioGCST903143330.12
7622Neutrophill count | Blood countUKBB000004970.12
7623TPI1 levelsGCST900886590.12
7624IDP dMRI TBSS ICVF Anterior limb of internal capsule LGCST900043440.12
7625KeloidGCST900186540.12
7626Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608)GCST902697050.12
7627Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T475ECGA0004750.12
7628IDP T1 FIRST left pallidum volumeGCST900024420.12
7629REG4 levelsGCST904704510.12
7630BAG6 levelsGCST904684180.12
7631Frailty (General Factor)GCST906240460.12
7632ADH4/SORD ratioGCST903131960.12
7633CCNE1 levelsGCST904685930.12
7634total cholesterol (maximum, inv-norm transformed)GCST904764180.12
7635Neutrophil countGCST900023980.12
7636Added salt consumptionGCST901330010.12
7637CD99/KITLG ratioGCST903139240.12
7638Other bacterial diseasesFING000009680.12
7639ADA2/VCAM1 ratioGCST903131670.12
7640Hepatic cancerGCST900186380.12
7641Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivityGCST903026980.12
7642Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T256ECGU0002560.12
76431-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000830.12
7644aparc-DKTatlas lh area precuneusGCST900032570.12
7645Total Lipids in Medium LDLGCST904988060.12
7646Duodenal ulcerGCST902709280.12
7647CLIP2/NT5C3A ratioGCST903141290.12
7648CCL5 levelsGCST904685840.12
7649IDP dMRI TBSS MO Pontine crossing tractGCST900039530.12
7650IDP SWI T2star right caudateGCST900038660.12
7651Concentration of medium LDL particlesGCST904988230.12
7652Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026510.12
7653SPARC/ZBTB16 ratioGCST903158750.12
7654CRELD1 levelsGCST904688580.12
7655T1 FreeSurfer DK lh lateraloccipital areaGCST903855980.12
7656Total fatty acid levelsGCST905022180.12
7657Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391ECGU0003910.12
7658Left ventricular stroke volumeGCST902681300.12
7659YBX1 levelsGCST900907990.12
7660CRADD/SIRT2 ratioGCST903142430.12
7661DTI TBSS L1 Cingulum cingulate gyrus LGCST903844630.12
7662KRT19 levelsGCST904697170.12
7663Cholesteryl Esters in VLDLGCST905002110.12
7664RELL1 levelsGCST902426250.12
7665ENPP6 levelsGCST904691170.12
7666Phospholipids to total lipids ratio in medium HDLGCST900929010.12
7667Irritable bowel syndromeFING000007020.12
7668Total triglycerides levelsGCST0036640.12
7669Triglycerides to total lipids ratio in IDLGCST900928420.12
7670aseg lh intensity Inf-Lat-VentGCST900037650.12
7671KYAT1 levelsGCST904697210.12
7672Phospholipid levels in medium HDLGCST900929000.12
7673Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T273ECGA0002730.12
7674FHIT levelsGCST904692380.12
7675Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST904762460.12
7676aseg lh volume Lateral-VentricleGCST900026160.12
7677aseg global volume Brain-StemGCST900026020.12
7678PRL levelsGCST904703320.12
7679Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370ECGA0003700.12
7680ANXA1 levelsGCST904683160.12
7681B4GALT1 levelsGCST904684120.12
7682Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979690.12
7683BAIAP2/MME ratioGCST903134530.12
7684DTI autoptx L1 ilf l tractGCST903851530.12
7685F-chocolate/coffee liking (derived food-liking factor)GCST900947350.12
7686Triglycerides in medium LDLGCST904988700.12
7687GABBR2 levelsGCST902412300.12
7688Uric acid levelsGCST902786460.12
7689GoutGCST903997010.12
7690DTI autoptx L2 slf l tractGCST903851870.12
7691Peak expiratory flowGCST0074300.12
7692T1 CAT volume R CrusIGCST903841200.12
7693DHX58 levelsGCST906182380.12
7694CXCL9 levelsGCST904689350.12
7695Total phospholipid levels in lipoprotein particlesGCST905001100.12
7696BAG6/WASF1 ratioGCST903134520.12
7697Monounsaturated fatty acids to total fatty acids percentageGCST905023880.12
7698IDP dMRI TBSS L3 Posterior limb of internal capsule RGCST900041890.12
7699Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB000005770.12
7700Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446ECGU0004460.12
7701Cholesterol to Total Lipids in Small VLDL percentageGCST904997640.12
7702Enterocolitis due to Clostridium difficileFING000005070.12
7703Liver condition (ex. cirrhosis)GCST904752700.12
7704T1 FreeSurfer pial rh pericalcarine areaGCST903858420.12
7705Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006400.12
7706TNFRSF11B levelsGCST904709030.12
7707Capers likingGCST900947240.12
7708Phospholipids in medium VLDL (UKB data field 23504)GCST902696010.12
7709End-diastolic bi-ventricular shape (principal component 8)GCST904484870.12
7710Variation in diet | DietUKBB000008920.12
7711Concentration of small LDL particles (UKB data field 23544)GCST902696410.12
7712aparc-pial lh area precuneusGCST900031650.12
7713Total Lipids in LDLGCST904984050.12
7714F2R/PDGFB ratioGCST903147330.12
7715Principal component-derived dietary pattern 17GCST901330220.12
7716Free cholesterol levels in very small VLDLGCST900930320.12
7717Types of transport used (excluding work) - Car/motor vehicle | Physical activityUKBB000008760.12
7718Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485ECGA0004850.12
7719NPTXR levelsGCST904700800.12
7720Cholesterol to Total Lipids in Medium VLDL percentageGCST904989260.11
7721Severity of induration at injection site at the injection site after COVID-19 booster vaccinationGCST904544090.11
7722Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393ECGU0003930.11
7723PADI2 levelsGCST904701420.11
7724Sebaceous cyst (PheCode 706.2)GCST904762130.11
7725Diastolic blood pressureGCST902786250.11
7726Thyroid peroxidase antibody levels in pregnancyGCST904352010.11
7727Cholesteryl esters in VLDL (UKB data field 23416)GCST902695130.11
7728ACE2 levelsGCST904681970.11
7729IDP dMRI TBSS OD Posterior limb of internal capsule RGCST900044200.11
7730FABP1/LGALS4 ratioGCST903147520.11
7731T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903206270.11
7732CPXM1/SPARC ratioGCST903142220.11
7733CUZD1 levelsGCST904689190.11
7734Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143ECGU0001430.11
7735NFX1 levelsGCST904700410.11
7736Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402ECGU0004020.11
7737aparc-Desikan rh area superiorparietalGCST900031350.11
7738Plasma glycocholenate sulfate* levels in chronic kidney diseaseGCST902652910.11
7739GZMA/IL12A_IL12B ratioGCST903150090.11
7740CD93/TNFRSF4 ratioGCST903139220.11
7741COQ7 levelsGCST904688310.11
7742PKLR/UBAC1 ratioGCST903156600.11
7743Pulse rate | Arterial stiffnessUKBB000007220.11
7744Right ventricular stroke volumeGCST901345900.11
7745Alanine levelsGCST0036660.11
7746rfMRI amplitudes (ICA100 node 12)GCST900046000.11
7747Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levelsGCST900602950.11
7748Phosphoglycerides levelsGCST904992650.11
7749Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998320.11
7750Triglycerides to total lipids ratio in very large VLDLGCST900930270.11
7751IDP dMRI TBSS MO Posterior limb of internal capsule LGCST900039710.11
7752Ever thought that life not worth living | Self-harm behavioursUKBB000002250.11
7753aparc-a2009s rh area S-oc-middle+LunatusGCST900034270.11
7754HPCAL1/SERPINB9 ratioGCST903150790.11
7755Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456ECGU0004560.11
7756DTI TBSS L3 External capsule RGCST903845560.11
7757Breast sizeGCST0066550.11
7758FABP1/FABP2 ratioGCST903147500.11
7759aseg global volume VentricleChoroidGCST900025980.11
7760Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T204ECGU0002040.11
7761TNFSF8 levelsGCST904709230.11
7762EGFLAM levelsGCST904690840.11
7763TOR1AIP1 levelsGCST904709350.11
7764Calcium | Blood biochemistryUKBB000001140.11
77651-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite levelGCST906164050.11
7766Body fat percentageGCST901037520.11
7767PLIN1 levelsGCST904702580.11
7768CRACR2A/IRAG2 ratioGCST903142270.11
7769Cholesterol in small VLDL (UKB data field 23512)GCST902696090.11
7770Phospholipids in small VLDL (UKB data field 23511)GCST902696080.11
7771Phospholipid levels in very small VLDLGCST901326590.11
7772Concentration of small VLDL particlesGCST900929750.11
7773Docosahexaenoic acid to total fatty acids percentageGCST905022850.11
7774Total lipids in IDL (UKB data field 23524)GCST902696210.11
7775Provencibacterium abundance in stoolGCST900325280.11
7776DNM3 levelsGCST904690220.11
7777Triglycerides in medium VLDLGCST904990650.11
7778SERPINE2 levelsGCST904705970.11
7779Restless leg syndromeFING000012550.11
7780CRIP2/SNCG ratioGCST903142620.11
7781HippSubfield lh volume CA3-bodyGCST900026800.11
7782Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422ECGU0004220.11
7783PPP1R2/USP8 ratioGCST903157230.11
7784CTSZ levelsGCST904689180.11
7785Concentration of very small VLDL particlesGCST905008260.11
7786Saturated fatty acids levelsGCST905021850.11
7787Triglycerides in IDL (UKB data field 23529)GCST902696260.11
7788BA-exvivo rh area BA6GCST900032270.11
7789aparc-pial rh area caudalmiddlefrontalGCST900031770.11
7790Excessive vomiting in pregnancyFING000005230.11
7791EDN1 levelsGCST904690730.11
7792Self-reported risk-taking behaviourGCST0068100.11
7793ADGRG1 levelsGCST904682400.11
7794SDC1 levelsGCST904705580.11
7795ThalamNuclei lh volume VPLGCST900027170.11
7796Triglyceride levels in chylomicrons and extremely large VLDLGCST905010750.11
7797Intervertebral disc disorders (PheCode 722)GCST904762370.11
7798Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccineGCST904486950.11
7799BRK1 levelsGCST904684690.11
7800Hyperplasia of prostate (PheCode 600)GCST904761530.11
7801Preeclampsia or other maternal hypertension (maternal genotype effect)GCST902699040.11
7802PPY levelsGCST904703090.11
7803ALDH1A1/RBKS ratioGCST903132470.11
7804DTI autoptx L2 ifo l tractGCST903851780.11
78051-arachidonoylglycerophosphoethanolamine levelsGCST902438080.11
7806Average diameter for LDL particlesGCST900928890.11
7807CA2/NSFL1C ratioGCST903135800.11
7808CETN2 levelsGCST904687210.11
7809Free cholesterol in LDL (UKB data field 23421)GCST902695180.11
7810Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276ECGU0002760.11
7811Docosahexaenoic acid levelsGCST905019840.11
7812LEP levelsGCST900120760.11
7813MMP9/OSM ratioGCST903154680.11
7814F-whole food liking (derived food-liking factor)GCST900948680.11
7815Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB000006250.11
7816Triglyceride levels in small LDLGCST900929660.11
7817Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470ECGA0004700.11
7818Calculus of kidney | genitourinaryUKBB000001150.11
7819Mouth/teeth dental problems - Dentures | MouthUKBB000004860.11
7820HSPB1/QDPR ratioGCST903150890.11
7821DTI TBSS MD Cingulum hippocampus LGCST903846090.11
7822Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivityGCST903026590.11
7823CRKL/PLA2G4A ratioGCST903142710.11
7824Polycystic ovarian syndrome, consortium definitionFING000011840.11
7825BCR/ICA1 ratioGCST903134930.11
7826HGF/MMP9 ratioGCST903150560.11
7827GP6/SCARF1 ratioGCST903149690.11
7828Age spotsGCST0060960.11
7829red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763630.11
7830Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133ECGU0001330.11
7831Cholesterol in medium VLDL (UKB data field 23505)GCST902696020.11
7832IDP dMRI TBSS ICVF Anterior corona radiata LGCST900043500.11
7833Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009490.11
7834ITGB1BP2/PTPN6 ratioGCST903152180.11
7835Nervous feelings | Mental healthUKBB000004950.11
7836BLVRB/HMBS ratioGCST903135260.11
7837Total fatty acid levelsGCST905022110.11
7838Leg fat percentage left (UKB data field 23115)GCST904681740.11
7839Blood cell traits latent factor 6 (red cell (and basophil))GCST905592480.11
7840ABHD14B/SCRN1 ratioGCST903131450.11
7841Total fatty acids levels (UKB data field 23442)GCST902695390.11
7842NUDT5/TXNRD1 ratioGCST903155820.11
7843Nephrotic syndromeGCST900186640.11
7844Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436ECGU0004360.11
7845aparc-DKTatlas rh area insulaGCST900032960.11
7846IgA nephropathy (IgA glomerulonephritis)FING000006600.11
7847SMNDC1 levelsGCST904706810.11
7848EDAR/IPCEF1 ratioGCST903145780.11
7849Gastrointestinal issues (confirmatory factor analysis Factor 31)GCST903093650.11
7850aparc-a2009s lh area G-precuneusGCST900033260.11
7851ICAM1/SELE ratioGCST903151160.11
7852RILPL2 levelsGCST904704700.11
7853Monounsaturated fatty acid levelsGCST905020290.11
7854Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007910.11
7855Cholesterol to Total Lipids in Small LDL percentageGCST904995640.11
7856T1 FreeSurfer a2009s rh S temporal sup areaGCST903849620.11
7857Takes medication for gout?GCST904763820.11
7858EIF1AX levelsGCST902411200.11
7859Ceramide (d17:1/24:0) levelsGCST900240330.11
7860ITGB1BP2/MED18 ratioGCST903152130.11
7861BACH1/HEXIM1 ratioGCST903134400.11
7862Flat foot [pes planus] (acquired)FING000005450.11
7863Monocyte percentage of white cellsGCST0046090.11
7864Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396ECGU0003960.10
7865REST UKBBICA NODEamps25 0006GCST903854890.10
7866CFD levelsGCST904687250.10
7867Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403ECGU0004030.10
7868IDP dMRI TBSS FA Genu of corpus callosumGCST900038790.10
7869aparc-pial rh area TotalSurfaceGCST900031740.10
7870CASP8/PPP3R1 ratioGCST903136540.10
7871CLEC4D/HGF ratioGCST903141100.10
7872DNA methylation GrimAge accelerationGCST900142880.10
7873Biological Mother: Coronary Artery / Coronary Heart DiseaseGCST904754880.10
7874Waist circumferenceGCST901037530.10
7875Cholesterol in Large LDLGCST904979190.10
7876CD63/CLEC1B ratioGCST903138630.10
7877Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392ECGU0003920.10
7878aparc-pial lh area postcentralGCST900031620.10
7879Major depressive disorderGCST0099790.10
7880Cholesteryl esters to total lipids ratio in medium LDLGCST900929070.10
7881Cholesteryl esters in IDL (UKB data field 23527)GCST902696240.10
7882IDP dMRI TBSS MD Cerebral peduncle LGCST900040420.10
7883Mean platelet volume during second trimester of pregnancyGCST903022300.10
7884Treatment/medication code - ibuprofen | MedicationsUKBB000008470.10
7885LILRA5 levelsGCST904697740.10
7886Left-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST903026600.10
7887Phospholipids to Total Lipids in Very Small VLDL percentageGCST905008660.10
7888IDP T1 FAST ROIs V cerebellum VIIbGCST900025760.10
7889Lesion of plantar nerveFING000007200.10
7890FLT4/KDR ratioGCST903148610.10
7891Phospholipids to Total Lipids in Medium VLDL percentageGCST904990430.10
7892CST6/FABP9 ratioGCST903143010.10
7893FUT3_FUT5/LILRA2 ratioGCST903148890.10
7894Docosahexaenoic acid to total fatty acids percentageGCST905022800.10
7895OLR1/OSM ratioGCST903155830.10
7896X-21441 levelsGCST902005810.10
7897AmygNuclei rh volume Medial-nucleusGCST900026630.10
7898aparc-DKTatlas rh area superiorparietalGCST900032920.10
7899Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270ECGU0002700.10
7900Volume of right lateral nucleusGCST904749220.10
7901Plasma cystathionine levels in chronic kidney diseaseGCST902649740.10
7902T1 FreeSurfer aseg Brain-StemGCST903841490.10
7903EBAG9/TBCC ratioGCST903145680.10
7904Statin medicationFING000013310.10
7905Docosahexaenoic acid to total fatty acids percentageGCST904972680.10
7906Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivityGCST903027740.10
7907WNT9A levelsGCST904710790.10
7908CNTNAP2 levelsGCST904688080.10
7909Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T274ECGA0002740.10
7910Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900254340.10
7911Omega-3 fatty acids to total fatty acids percentageGCST905024480.10
7912SERPINB1/SERPINB6 ratioGCST903158260.10
7913EREG/HBEGF ratioGCST903147020.10
7914CD40LG/EGF ratioGCST903138190.10
7915HippSubfield lh volume subiculum-headGCST900026710.10
7916Personal history of medical treatment | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006430.10
7917APOB levelsGCST904971300.10
7918CLEC1B/DIABLO ratioGCST903140870.10
7919Pain medicine use during menstruationGCST0066370.10
7920Cholesteryl Esters in LDLGCST904983630.10
7921Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140ECGU0001400.10
7922GLOD4/MIF ratioGCST903149390.10
7923CAPN3 levelsGCST904685380.10
7924PDGFRA levelsGCST904210930.10
7925Omega-3 fatty acid levelsGCST905024410.10
7926Citrate levels (UKB data field 23473)GCST902695700.10
7927Monounsaturated fatty acids to total fatty acids percentageGCST905020430.10
7928Total esterified cholesterol levels (UKB data field 23415)GCST902695120.10
7929CD55/PTGDS ratioGCST903138470.10
7930Triglyceride levels in small HDLGCST900929540.10
7931Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450ECGU0004500.10
7932Diastolic blood pressure, manual reading | Blood pressureUKBB000001800.10
7933Cholesteryl Esters in Medium LDLGCST904987390.10
7934Free cholesterol in IDL (UKB data field 23528)GCST902696250.10
7935BSG/IL12A_IL12B ratioGCST903135320.10
7936Urea | Blood biochemistryUKBB000008850.10
79371-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996520.10
7938estimated glomerular filtration rate (eGFR, mean, inv-norm transformed)GCST904752820.10
7939X-24328 levelsGCST902006240.10
7940Left-hemisphere control network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027460.10
7941Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123ECGU0001230.10
7942Number of sexual partners in opposite-sex sexual behaviorGCST900264820.10
7943Urea levels (UKB data field 30670)GCST904681080.10
7944Free cholesterol to total lipids ratio in very small VLDLGCST900930330.10
7945Red cell distribution widthGCST900024040.10
7946CD22/FOLR2 ratioGCST903137580.10
7947HBEGF levelsGCST904694330.10
7948Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027480.10
7949Common executive functionGCST905031150.10
7950Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655080.10
7951Happiness | Mental healthUKBB000003050.10
7952NBN levelsGCST904700020.10
7953Visual disturbancesFING000014370.10
7954DAB2/NCK2 ratioGCST903143670.10
7955Phospholipids to total lipids ratio in chylomicrons and extremely large VLDLGCST900930490.10
7956ENO2/MGLL ratioGCST903146630.10
7957Total phospholipids in lipoprotein particles (UKB data field 23411)GCST902695080.10
7958Phospholipids to total lipids in large LDL percentage (UKB data field 23614)GCST902697110.10
79593-methyl-2-oxovalerate levelsGCST902434850.10
7960TGFBI/VASN ratioGCST903159150.10
7961X-11550 levelsGCST902436480.10
7962ALDH1A1/SORD ratioGCST903132480.10
7963Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB000008370.10
7964Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208ECGU0002080.10
7965T1 FreeSurfer a2009s lh G front sup thicknessGCST903847570.10
7966IDP dMRI ProbtrackX ICVF ml rGCST900043930.10
7967EIF3J levelsGCST902411220.10
7968DKK3/LTBP2 ratioGCST903144870.10
7969Alpha angleGCST901296350.10
7970Acute laryngitis and tracheitisFING000000230.10
7971PCDH17/TEK ratioGCST903156060.10
7972Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53ECGA0000530.10
7973Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T127ECGU0001270.10
7974SERPINA6 levelsGCST904705860.10
7975Total Ceramide levelsGCST900245780.10
7976CALCOCO1/MAP3K5 ratioGCST903136050.10
7977AXL/IL18BP ratioGCST903134200.10
7978F-savoury food liking (derived food-liking factor)GCST900948330.10
7979IDP dMRI TBSS ICVF Medial lemniscus LGCST900043360.10
7980aparc-DKTatlas lh area rostralmiddlefrontalGCST900032590.10
7981What is your weight? (pounds, inv-normal transformed)GCST904764690.10
7982Cholesteryl esters in small LDL (UKB data field 23548)GCST902696450.10
7983Homeostasis model assessment of beta-cell functionGCST0051800.10
7984Chronic renal failure [CKD] (PheCode 585.3)GCST904761230.10
7985Cognitive function (baseline)GCST905658360.10
7986Monounsaturated fatty acid levelsGCST905020300.10
7987Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404ECGU0004040.10
7988Left ventricular end-diastolic volumeGCST902681240.10
7989FrecklesGCST0060910.10
7990CEACAM1 levelsGCST904686920.10
7991Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T223ECGA0002230.10
7992Triglycerides in medium HDL (UKB data field 23571)GCST902696680.10
7993ADH4 levelsGCST904682440.10
7994POMC levelsGCST904702840.10
7995Phospholipids to Total Lipids in Medium LDL percentageGCST904988470.10
7996VWC2 levelsGCST904710640.10
7997Follicle stimulating hormone levelsGCST904834760.10
7998CEACAM8/RNASE3 ratioGCST903140040.10
7999Current tobacco smoking | SmokingUKBB000001610.10
8000CD274/EFNA4 ratioGCST903137680.10